Rare diseases
Investigational molecules
Locations
Study of Empagliflozin for Patients with Autosomal Dominant Polycystic Kidney Disease
GermanyStudy on Empagliflozin's Effect on Heart Function in Non-Diabetic Pre-Heart Failure Patients Using Fitbit and mHealth for Exercise Guidance
IrelandRemote Study on Empagliflozin and Finerenone for Reducing Kidney Issues in Type 2 Diabetes Patients
The NetherlandsStudy on the Effectiveness and Safety of Finerenone and Empagliflozin in Adults with Chronic Kidney Disease and Type 2 Diabetes
BelgiumStudy on the Effectiveness and Safety of Adding Pioglitazone to Metformin and Empagliflozin for Patients with Type 2 Diabetes with Poor Blood Sugar Control
PolandStudy on Empagliflozin for Patients with Aortic Stenosis After Aortic Valve Replacement
DenmarkStudy on the Effect of Empagliflozin, Acetylcholine Chloride, Insulin Aspart, and Sodium Nitroprusside Dihydrate on Heart Failure with Preserved Ejection Fraction Patients
The NetherlandsStudy on Starting Valsartan, Sacubitril, and Empagliflozin for Patients with Heart Failure with Reduced Ejection Fraction
PortugalStudy on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis
AustriaStudy on the Effects of Empagliflozin on Blood Sugar Levels in Patients with HNF1A-MODY Diabetes
DenmarkEvaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk
AustriaStudy of empagliflozin to improve exercise capacity in patients with hypertrophic cardiomyopathy
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
